Latest News for: Pharmaceutical sources

Edit

Global Atypical Hemolytic Uremic Syndrome Market to 2030 - Insights, Epidemiology and Market Forecasts - ResearchAndMarkets.com

The Marshall News Messenger 25 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 25, 2021-- ... Companies Mentioned. Alexion PharmaceuticalsOmeros CorporationNovartis PharmaceuticalsHoffmann-La RocheChugai Pharmaceutical ... 1 ... Alexion Pharmaceuticals ... Alexion Pharmaceuticals ... Novartis Pharmaceuticals ... Hoffmann-La Roche/Chugai Pharmaceutical ... View source version on businesswire.com. ... HEALTH PHARMACEUTICAL. SOURCE.
Edit

West's NovaGuard® SA Pro Safety System Recognized for Best Technologies Innovation at INTERPHEX

The Bradford Era 25 Oct 2021
25, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc ... The Best Technologies Innovation Award recognizes cutting-edge technologies, either new technologies or a novel implementation of existing technologies, that have the potential to change the way pharmaceutical and biotechnology companies operate ... SOURCE West Pharmaceutical Services, Inc.
Edit

Herceptin (Trastuzumab) Biosimilars Market 2021: Focus on Approved & Launched Biosimilars, Investigational & Research Use ...

The Marshall News Messenger 25 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 25, 2021--. The report has been added to ResearchAndMarkets.com's offering ... The report features the following details. ... ResearchAndMarkets.com is the world's leading source for international market research reports and market data ... View source version on businesswire.com.. CONTACT ... KEYWORD. ... HEALTH PHARMACEUTICAL. SOURCE ... PUB.
Edit

Europe Glomerulonephritis Markets and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug ...

The Marshall News Messenger 25 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 25, 2021--. The report has been added to ResearchAndMarkets.com's offering ... This research analyzes and forecasts Glomerulonephritis market size and drug sales ... Research Scope.. Countries ... Find out the market shares for key drugs by countries ... View source version on businesswire.com. ... PHARMACEUTICAL HEALTH OTHER HEALTH. SOURCE.
Edit

Cedilla Therapeutics Completes $82.6M Series B Financing

Hastings Tribune 25 Oct 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 25, 2021-- ... Dr. Glucksmann continued, “We are pleased to welcome Jake to our Board of Directors ... About Cedilla Therapeutics ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20211025005020/en/. CONTACT ... ONCOLOGY HEALTH GENERAL HEALTH RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY. SOURCE.
Edit

Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for ...

The Marshall News Messenger 25 Oct 2021
“We believe that molnupiravir will be an important addition to the range of public health tools to fight COVID-19 – including the vaccines developed by the research-based pharmaceutical industry, which remain essential and are the first-line of defense against this pandemic.” ... View source version on businesswire.com. ... SOURCE.
Edit

Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability ...

The Marshall News Messenger 25 Oct 2021
OXFORD, England--(BUSINESS WIRE)--Oct 25, 2021-- ... This is the first clinical study to measure the pharmacokinetics and metabolism of 5-MeO-DMT delivered intranasally ... Phase 1 study overview ... Beckley Psytech - ... View source version on businesswire.com.. CONTACT ... ALTERNATIVE MEDICINE MENTAL HEALTH HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY. SOURCE.
Edit

Global Macular Edema Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, ...

The Marshall News Messenger 25 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 25, 2021--. The report has been added to ResearchAndMarkets.com's offering ... This research analyzes and forecasts Macular Edema market size and drug sales ... Research Scope.. Countries ... Benefits of this Research. ... Key Topics Covered.. 1 ... View source version on businesswire.com. ... PHARMACEUTICAL OPTICAL HEALTH CLINICAL TRIALS. SOURCE.
Edit

Europe Deep Vein Thrombosis Market and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug ...

The Marshall News Messenger 25 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 25, 2021--. The report has been added to ResearchAndMarkets.com's offering ... This research analyzes and forecasts Deep Vein Thrombosis market size and drug sales ... Research Scope.. Countries ... Find out the market shares for key drugs by countries ... View source version on businesswire.com. ... PHARMACEUTICAL HEALTH CARDIOLOGY. SOURCE.
Edit

Second Dupixent® (dupilumab) Phase 3 Eosinophilic Esophagitis Trial to Demonstrate Significant Disease Improvements, Underscoring Role ...

Finger Lakes Times 25 Oct 2021
Regeneron Pharmaceuticals, Inc ... This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc ... Pharmaceutical Industries Ltd ... SOURCE Regeneron Pharmaceuticals, Inc.
Edit

Pomerantz Law Firm Announces the Filing of a Class Action Against BioMarin Pharmaceutical Inc. and ...

The Salamanca Press 23 Oct 2021
23, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against BioMarin Pharmaceutical Inc ... View original content to download multimedia.https.//www.prnewswire.com/news-releases/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-biomarin-pharmaceutical-inc-and-certain-officers--bmrn-301407013.html.
Edit

Up To 95 Percent of Serious Adverse Reactions To Drugs Under-Reported

Principia Scientific 23 Oct 2021
How common is it for mild, severe or death related adverse reactions for drugs or vaccines to go unreported? An important question because without reports, researchers cannot relay important cost benefit analysis of pharmaceutical products to the general population ... Why don’t they provide any sources or data for their claim?.
Edit

Global Glaucoma Therapeutics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and ...

The Marshall News Messenger 22 Oct 2021
Aerie Pharmaceuticals Inc.Allergan PLCBausch & Lomb Incorporated (Bausch Health Companies Inc.)Inotek Pharmaceuticals Corp.Merck & Co. Inc.Novartis AGPfizer Inc.Santen Pharmaceutical Co. Ltd.SIFI S.p.ATeva Pharmaceutical Industries Ltd ... View source version on businesswire.com. ... PHARMACEUTICAL HEALTH OPTICAL. SOURCE.
Edit

Worldwide Asthma Therapeutics Industry to 2026 - Featuring AstraZeneca, Abbot and Amgen Among Others - ResearchAndMarkets.com

The Marshall News Messenger 22 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 22, 2021-- ... Companies Mentioned ... Inc.Novartis AGSunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.)Teva Pharmaceutical Industries Ltd ... Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma ... View source version on businesswire.com. ... HEALTH PHARMACEUTICAL. SOURCE ... PUB.
Edit

Outlook on the Diltiazem Global Market to 2028 - by Product Type, Application and Geography ...

The Marshall News Messenger 22 Oct 2021
DUBLIN--(BUSINESS WIRE)--Oct 22, 2021--. The report has been added to ResearchAndMarkets.com's offering ... Bausch HealthTeva Pharmaceutical Industries LtdMylan N.VAthenexPfizer, IncGlenmarkSandoz (Novartis Ag)Sun Pharmaceutical Company LtdHikma PharmaceuticalsZydus Pharmaceuticals ... View source version on businesswire.com. ... HEALTH PHARMACEUTICAL. SOURCE.
×